These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 8281876)
21. A relevant experimental model for human bronchiolitis obliterans syndrome. Atanasova S; Hirschburger M; Jonigk D; Obert M; Petri K; Evers A; Hecker A; Schmitz J; Kaufmann A; Wilhelm J; Chakraborty T; Warnecke G; Gottlieb J; Padberg W; Grau V J Heart Lung Transplant; 2013 Nov; 32(11):1131-9. PubMed ID: 24050896 [TBL] [Abstract][Full Text] [Related]
22. Long-term outcomes and management of lung transplant recipients. Costa J; Benvenuto LJ; Sonett JR Best Pract Res Clin Anaesthesiol; 2017 Jun; 31(2):285-297. PubMed ID: 29110800 [TBL] [Abstract][Full Text] [Related]
23. [Lung transplant]. Espinosa M; Rodil R; Goikoetxea MJ; Zulueta J; Seijo LM An Sist Sanit Navar; 2006; 29 Suppl 2():105-12. PubMed ID: 16998519 [TBL] [Abstract][Full Text] [Related]
24. Are heart-lung transplant recipients protected from developing bronchiolitis obliterans syndrome? Moffatt-Bruce SD; Karamichalis J; Robbins RC; Whyte RI; Theodore J; Reitz BA Ann Thorac Surg; 2006 Jan; 81(1):286-91; discussion 291. PubMed ID: 16368382 [TBL] [Abstract][Full Text] [Related]
25. Immunologic consequences of transplantation. Keenan RJ; Zeevi A Chest Surg Clin N Am; 1995 Feb; 5(1):107-20. PubMed ID: 7743142 [TBL] [Abstract][Full Text] [Related]
30. Pulmonary disease caused by Mycobacterium chelonae in a heart-lung transplant recipient with obliterative bronchiolitis. Trulock EP; Bolman RM; Genton R Am Rev Respir Dis; 1989 Sep; 140(3):802-5. PubMed ID: 2506786 [TBL] [Abstract][Full Text] [Related]
31. Effects of prophylactic use of sirolimus on bronchiolitis obliterans syndrome development in lung transplant recipients. Sacher VY; Fertel D; Srivastava K; Panos A; Nguyen D; Baxter T; Shafazand S; Pham SM Ann Thorac Surg; 2014 Jan; 97(1):268-74. PubMed ID: 24119986 [TBL] [Abstract][Full Text] [Related]
32. The natural history of obliterative bronchiolitis and occlusive vascular disease of patients following heart-lung transplantation. Scott JP; Higenbottam TW; Clelland C; Hutter JA; Stewart S; Otulana BA; Wallwork J Transplant Proc; 1989 Feb; 21(1 Pt 3):2592-3. PubMed ID: 2539680 [No Abstract] [Full Text] [Related]
33. [Current status of lung transplantation]. García Río FJ; García Talavera I; Vázquez M; Villasante C Rev Clin Esp; 1992 Feb; 190(2):85-9. PubMed ID: 1561445 [TBL] [Abstract][Full Text] [Related]
34. Lung and heart-lung transplantation. Evolution and new applications. Bolman RM; Shumway SJ; Estrin JA; Hertz MI Ann Surg; 1991 Oct; 214(4):456-68; discussion 469-70. PubMed ID: 1953098 [TBL] [Abstract][Full Text] [Related]
35. Survival benefits of heart and lung transplantation. Van Trigt P; Davis RD; Shaeffer GS; Gaynor JW; Landolfo KP; Higginbotham MB; Tapson V; Ungerleider RM Ann Surg; 1996 May; 223(5):576-84. PubMed ID: 8651748 [TBL] [Abstract][Full Text] [Related]
36. Risk factors for the development of obliterative bronchiolitis after lung transplantation. Girgis RE; Tu I; Berry GJ; Reichenspurner H; Valentine VG; Conte JV; Ting A; Johnstone I; Miller J; Robbins RC; Reitz BA; Theodore J J Heart Lung Transplant; 1996 Dec; 15(12):1200-8. PubMed ID: 8981205 [TBL] [Abstract][Full Text] [Related]